Screen-detected breast cancers have a lower mitotic activity index

British Journal of Cancer

Volumn 82, Issue 2, 2000, Pages 381-384

  Groenendijk, R P R ^a   Bult, P ^a   Tewarie, L ^a   Peer, P G M ^a   Van Der Sluis, R F ^a   Ruers, T J M ^a   Wobbes, T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Activity; Breast; Cancer; Index; Screening mitotic

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 0033965994     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0930     Document Type: Article

References (36)

1. Aaltomaa S, Lipponen P, Eskelinen M, Alhave E and Syrjänen K (1991) Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer. Eur J Surg 157: 319-324
2. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E and Syrjänen K (1993) Predictive value of a morphometric prognostic index in female breast cancer. Oncology 50: 57-62
3. Baak JPA (1985) The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer. Histopathology 9: 437-444
4. Baak JPA, Dop van H, Kurver PHJ and Hermans J (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374-382
5. Baak JPA et al (1989) The multicenter morphometric mammary carcinoma project (MMMCP): a nation wide prospective study on reproducibility and prognostic power of routine quantitative assessments in the Netherlands. Pathol Res Pract 185: 664-670
6. Baak JPA, Wisse-Brekelmans ECM, Kurver PHJ, Gorp van LHM, Voorhorst FJ and Miettinen BS (1992) Regional differences in breast cancer survival are correlated with differences in differentiation and rate of proliferation. Hum Pathol 23: 989-992
7. Baak JPA, Diest van PJ, Benraadt T, Matze-Cok E, Brugghe J, Schuurmans LT, Littooy JJ and other MMMCP collaborators (1993) The multi-center morphometric mammary carcinoma project (MMMCP) in the Netherlands: value of morphometrically assessed proliferation and differentiation. J Cell Biochem Suppl 17G: 220-225
8. Borras JM, Espinas JA, Beemsterboer PM, Granados A and Koning de HJ (1998) Anticipating the consequences for the primary therapy of breast cancer after introducing screening. A more global picture for health care policy making. Int J Technol Assess Health Care 14: 268-276
9. Collan YUI et al (1996) Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol Res Pract 192: 931-941
10. Diest van PJ et al (1992a) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 6: 603-607
11. Diest van PJ, Fleege JC and Baak JPA (1992b) Syntactic structure analysis in invasive breast cancer: analysis of reproducibility, biologic background and prognostic value. Hum Pathol 23: 876-883
12. Diest van PJ, Baak JPA, Matze-Cok P and Bacus SS (1992c) Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and Her-2/Neu oncoprotein expression. Pathol Res Pract 188: 344-349
13. Dijck van JA, Broeders MJ and Verbeek AL (1997a) Mammographic screening in older women. Is it worthwhile? Drugs Aging 10: 69-79
14. Dijck van JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, Straatman H and Werre JM (1997b) Breast cancer mortality in a nonrandomized trial on mammographic screening in women over age 65. Int J Cancer 70: 164-168
15. Elwood JM, Cox B and Richardson AK (1993) The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Triats: Doc No 32
16. Elston CE (1987) Grading of invasive carcinoma of the breast. In: Diagnostic Histopathology of the Breast, Page DL and Anderson TJ (eds), pp. 300-307. Churchill Livingstone: Edinburgh
17. Fracheboud J, Koning de HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL, Ineveld van BM, Bruyn de AE and Maas van der PJ (1998) Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 75: 694-698
18. Freund KM, Burns RB and Antab L (1998) Improving residents' performances of clinical breast examination. J Cancer Educ 13: 20-25
19. Harris KM and Vogel VG (1997) Breast cancer screening. Cancer Metastasis Rev 16: 231-262
20. Jannink I, Diesl van PJ and Baak JPA (1995) Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients. Hum Pathol 26: 1086-1092
21. Linden van der HC, Baak JPA, Lindeman J, Hermans F and Meyer CLJM (1986) Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results. J Clin Pathol 39: 603-609
22. Linden van der JC, Baak JPA, Lindeman J, Hermans J and Meyer CJLM (1987) Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. J Clin Pathol 40: 302-306
23. Linden van der JC, Lindeman J, Baak JPA, Meijer CJLM and Herman CJ (1989) The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 10: 56-61
24. Maestro C, Cazenave F, Marey PY, Bruneton JN, Chauvel C and Bleuse A (1998) Systematic ultrasonography in asymplomatic dense breasts. Eur J Radiol 26: 254-256
25. Peer PG, Verbeek AL, Straatman H, Hendriks JH and Holland R (1996) Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 38: 153-160
26. Peeters PHM, Miltenburg GAJ, Fracheboud J, Gimbrère CHF, Hogervorst JMW and Colette HJA (1998) Seventeen-year evaluation of breast cancer screening: the DOM project, the Netherlands. Br J Cancer 78: 962-965
27. Schroën AMA, Wobbes TH and Sluis van der RF (1996) Interval carcinomas of the breast: a group with intermediate outcome. J Surg Oncol 63: 141-144
28. Schroën AMA, Wobbes Th and Sluis van der RF (1998) Infiltrating lobular carcinoma of the breast detected by screening. Br J Surg 85: 390-392
29. Smart CR (1992) Mammographic screening: efficacy and guidelines. Curr Opin Radiol 4: 108-117
30. Tabàr L et al (1985) Reduction in mortality from breast cancer alter mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1: 829-832
31. Theissig F, Baak JPA, Schuurmans L, Haroske G, Meyer W and Kunze KD (1996) Blind multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer. Anal Cell Pathol 10: 85-99
32. Uyterlinde AM, Schipper NW and Baak JPA (1987) Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer. J Clin Pathol 40: 1432-1436
33. Uyterlinde AM, Schipper NW, Baak JPA, Peterse H and Matze E (1988) Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer. Am J Clin Path 89: 301-307
34. Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E and Meyer CJL (1990) Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 45: 1-7
35. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F and Day NE (1984) Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1: 1222-1224
36. Wolfe JN (1991) Breast cancer screening. A brief historical review. Breast Cancer Res Treat 18: 89-92